Results 181 to 190 of about 255,748 (249)

MMPred: a tool to predict peptide mimicry events in MHC class II recognition. [PDF]

Front Genet
Guerri F, Junet V, Farrés J, Daura X.
europepmc   +1 more source

Tumor immunotherapy by converting tumor cells to MHC class II?positive, Ii protein?negative phenotype

, 2003
Xueqing Lu, Nikoletta L. Kallinteris, Jizhi Li, Shuzhen Wu, Yu Li, Zhong Jiang, Gilda G. Hillman, Joseph V. Gulfo, Robert E. Humphreys, Minzhen Xu   +9 more
openalex   +2 more sources

Exploring diverse approaches for predicting interferon-gamma release: utilizing MHC class II and peptide sequences. [PDF]

Brief Bioinform
Omran A, Amberg A, Ecker GF.
europepmc   +1 more source

A general system for targeting MHC class II-antigen complex via a single adaptable loop. [PDF]

Nat Biotechnol
Du H, Liu J, Jude KM, Yang X, Li Y, Bell B, Yang H, Kassardjian A, Blackson W, Mobedi A, Parekh U, Parra Sperberg RA, Julien JP, Mellins ED, Garcia KC, Huang PS.   +15 more
europepmc   +1 more source

Intravital imaging the formation and resolution of MHC class II-positive T cell activation niches [PDF]

David Oleksyn, Jim Miller
openalex   +1 more source

Unveiling signaling pathways inducing MHC class II expression in neutrophils. [PDF]

Front Immunol
Forrer P, Palianina D, Stühler C, Kreuzaler M, Roux J, Li J, Schmutz C, Burckhardt D, Franzeck F, Finke D, Schmidt A, Bumann D, Khanna N.   +12 more
europepmc   +1 more source

Multi-omic analysis identifies erythroid cells as the major population in mouse placentas expressing genes for antigen presentation in MHC class II, chemokines, and antibacterial immune response. [PDF]

Front Immunol
Perik-Zavodskaia O, Perik-Zavodskii R, Alrhmoun S, Nazarov K, Shevchenko J, Zaitsev K, Sennikov S.   +6 more
europepmc   +1 more source

MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma. [PDF]

Commun Med (Lond)
Claeys A, Van den Eynden J.
europepmc   +1 more source

Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A^b. [PDF]

Nat Commun
Ming Q, Antfolk D, Price DA, Manturova A, Medina E, Singh S, Mason C, Tran TH, Smalley KSM, Leung DW, Luca VC.   +10 more
europepmc   +1 more source

Applications of molecular modeling and supramolecular chemistry: de novo design of MHC class II inhibitors and rational design of ligands for asymmetric catalysis

, 1998
Laurent Ducry
openalex   +2 more sources